Get startedLog in
    Picture of Otofarma SpA logo

    OTO — Otofarma SpA Income Statement

    0.000.00%
    it flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Otofarma SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2024
    December 31st
    Period Length:12 M
    Source:PROSPECTUS
    Standards:
    IAS
    Status:Final
    Revenue
    Total Revenue15.1
    Cost of Revenue
    Gross Profit5.88
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Other Operating Expenses
    Total Operating Expenses13.1
    Operating Profit1.94
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes1.68
    Provision for Income Taxes
    Net Income After Taxes0.695
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income0.699
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income0.698
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.157